163 related articles for article (PubMed ID: 11103941)
1. Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells.
Knight EL; Warner AJ; Maxwell A; Prigent SA
Oncogene; 2000 Nov; 19(47):5398-405. PubMed ID: 11103941
[TBL] [Abstract][Full Text] [Related]
2. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.
Takahashi T; Yamaguchi S; Chida K; Shibuya M
EMBO J; 2001 Jun; 20(11):2768-78. PubMed ID: 11387210
[TBL] [Abstract][Full Text] [Related]
3. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
Qi JH; Claesson-Welsh L
Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.
Gingras D; Lamy S; Béliveau R
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):273-80. PubMed ID: 10816419
[TBL] [Abstract][Full Text] [Related]
5. Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole.
Faehling M; Kroll J; Föhr KJ; Fellbrich G; Mayr U; Trischler G; Waltenberger J
FASEB J; 2002 Nov; 16(13):1805-7. PubMed ID: 12354692
[TBL] [Abstract][Full Text] [Related]
6. Lipocortin V may function as a signaling protein for vascular endothelial growth factor receptor-2/Flk-1.
Wen Y; Edelman JL; Kang T; Sachs G
Biochem Biophys Res Commun; 1999 May; 258(3):713-21. PubMed ID: 10329451
[TBL] [Abstract][Full Text] [Related]
7. The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma.
Sawano A; Takahashi T; Yamaguchi S; Shibuya M
Biochem Biophys Res Commun; 1997 Sep; 238(2):487-91. PubMed ID: 9299537
[TBL] [Abstract][Full Text] [Related]
8. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
9. Selective killing of RPE with a vascular endothelial growth factor chimeric toxin.
Hoffmann S; Masood R; Zhang Y; He S; Ryan SJ; Gill P; Hinton DR
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2389-93. PubMed ID: 10892888
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells.
Herold-Mende C; Steiner HH; Andl T; Riede D; Buttler A; Reisser C; Fusenig NE; Mueller MM
Lab Invest; 1999 Dec; 79(12):1573-82. PubMed ID: 10616207
[TBL] [Abstract][Full Text] [Related]
11. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors.
Pajusola K; Aprelikova O; Pelicci G; Weich H; Claesson-Welsh L; Alitalo K
Oncogene; 1994 Dec; 9(12):3545-55. PubMed ID: 7970715
[TBL] [Abstract][Full Text] [Related]
12. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites.
Cunningham SA; Arrate MP; Brock TA; Waxham MN
Biochem Biophys Res Commun; 1997 Nov; 240(3):635-9. PubMed ID: 9398617
[TBL] [Abstract][Full Text] [Related]
13. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
[TBL] [Abstract][Full Text] [Related]
14. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
Landgren E; Schiller P; Cao Y; Claesson-Welsh L
Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
[TBL] [Abstract][Full Text] [Related]
15. Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells.
Riesterer O; Zingg D; Hummerjohann J; Bodis S; Pruschy M
Oncogene; 2004 Jun; 23(26):4624-35. PubMed ID: 15064712
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
17. [Autocrine stimulation of receptor-tyrosine kinases (RTK) in human tumor cell lines in vitro: therapeutic implications].
Gaumann A; Groot M; Drexler HC; Breier G
Verh Dtsch Ges Pathol; 2003; 87():232-9. PubMed ID: 16888917
[TBL] [Abstract][Full Text] [Related]
18. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
[TBL] [Abstract][Full Text] [Related]
19. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
[TBL] [Abstract][Full Text] [Related]
20. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM
Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]